Navigation Links
Scientists Identify the Most Significant Single Predictor of Aggressive Prostate Cancer

An elevated rate of increase in prostate specific antigen (PSA) levels is the most significant predictor of aggressive form of prostate cancer, according to a new study published in the journal Cancer.

The study suggests if the rate of PSA increase prior to treatment (PSA Velocity) is more than 2 ng/ml/year, it is an indication of a high risk of death from prostate cancer.

According to the researchers, the new findings attain significance with recent studies suggesting that factors like microscopic features of the tumour (Gleason score), and size, spread and location of the disease are not very effective to determine prognosis.

Dr. Anthony DAmico of Bostons Brigham and Womens Hospital and colleagues characterised PSA velocity significant in prostate cancer-specific mortality (PCSM) rates following treatment with radical prostatectomy (RP) or radiation therapy (RT).

The researchers reviewed data from 948 men with localized prostate cancer who had one or more high-risk factors, and found that PSA velocity appeared to be the most important single prognostic factor. They observed that men who had multiple risk factors died from their disease significantly earlier than those who had only one factor.

Among men who underwent treatment with RP or RT, 44 per cent and 28 per cent, respectively, had pre-treatment PSA velocities of 2 ng/ml/year as their only identified high-risk factor.

It was observed that of those men who died with only one identified high-risk factor, 88 per cent of RP-treated patients and 80 per cent of RT-treated patients had pre-treatment PSA velocities of 2 ng/ml/year.

The study authors have also pointed out at the results of various other studies that have shown that the time to death shortens as PSA velocity increases, which suggests that further research should examine using stratified PSA velocities to assess risk in men with localised disease.

"These findings hi ghlight the ability of a pre-treatment PSA velocity 2 ng/ml/year alone to identify men with aggressive prostate cancer and in whom effective systemic treatment in addition to mono-therapy with RP or RT is needed to decrease PCSM rates," conclude the authors.


'"/>




Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2017)... ... May 27, 2017 , ... Most us are familiar with ... new study from the Osteoarthritis Initiative shows that certain people who experience ... this in advance may give doctors the opportunity to treat patients before the problem ...
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs from ... May 30th and 31st at The Four Seasons Hotel Boston. , The ... life sciences, offering exclusive access to key decision makers who influence deal making ...
(Date:5/26/2017)... Clara, Calif. (PRWEB) , ... May 26, 2017 ... ... announces the integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware ... provides a consistent, browser-based interface for diagnostic device operations. With this platform, initializing ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... focusing on the Peace Agreements being discussed by President Donald Trump and the rest ... to try to speed up peace talks in the continuous battle between Israel and ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... 2017  A new tight-tolerance microextrusion medical tubing ... materials, is being launched by Natvar, a Tekni-Plex ... in recent years to service a wide variety ... More expensive materials such as glass and fluoropolymers ... to their ability to consistently hold tolerances. This ...
(Date:5/3/2017)... 2017  Kalorama Information notes that transplant diagnostics ... year and this is projected to continue to ... (HSCT) or bone marrow transplants require histocompatibility between ... for this task. This according to a new ... The various PCR-based methodologies, Sanger sequencing and NGS ...
(Date:5/2/2017)... NEW YORK and LONDON ... distributor of market intelligence, MarketResearch.com is pleased to announce ... Consulting AB that allows for the marketing and ... market analyses through the MarketResearch.com website. The ... access to complete product descriptions and tables of contents ...
Breaking Medicine Technology: